Bundled Cancer Screening and Genetic Services Navigation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-74
SponsorGeorgetown University
About this trial
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.
Eligibility criteria
Qualifiers
Seeking screening navigation services through programs at a participating site (Georgetown Lombardi Cancer Center or Helen F. Graham Cancer Center & Research Institutes)
Eligible for breast cancer screening while also due and eligible for colorectal cancer screening (per USPSTF guidelines)
Female sex
Aged 45-74
Disqualifiers
Not engaged with or planning to use navigation programs at Georgetown Lombardi Cancer Center and Helen F. Graham Cancer Center & Research Institute
Not eligible for breast cancer screening or not due and eligible for colorectal cancer screening (per USPSTF guidelines)
History of breast and/or colorectal cancer; or Reporting symptoms related to breast and/or colorectal cancer (e.g., GI bleeding, breast mass)
Male sex, Intersex, or other sex
Trial design
Treatments tested in this trial
- Breast cancer screening navigation
- Multicancer screening navigation
- Usual care genetics referral
- Pretest education + usual care genetics referral
Treatment groups
820 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Georgetown University
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov